Centessa Pharmaceuticals (CNTA) News Today $15.48 -0.09 (-0.58%) Closing price 04:00 PM EasternExtended Trading$15.46 -0.02 (-0.13%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CNTA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Truist Securities Initiates Coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (CNTA) with Buy RecommendationJuly 23 at 9:01 AM | msn.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) CEO Sells $875,600.00 in StockJuly 22 at 4:53 AM | insidertrades.comCentessa Pharmaceuticals (NASDAQ:CNTA) Now Covered by Truist FinancialJuly 22 at 2:15 AM | americanbankingnews.comSaurabh Saha Sells 55,000 Shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) StockJuly 21 at 9:41 PM | marketbeat.comTruist Financial Begins Coverage on Centessa Pharmaceuticals (NASDAQ:CNTA)July 21 at 8:15 AM | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives $27.89 Consensus Price Target from AnalystsJuly 19, 2025 | americanbankingnews.comWildcat Capital Management LLC Invests $4.05 Million in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA)July 17, 2025 | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of "Buy" by AnalystsJuly 16, 2025 | marketbeat.comCentessa Pharmaceuticals Advances Neurological Drug ORX142 to Clinical TrialsJuly 15, 2025 | msn.comCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Up 7.9% - Still a Buy?July 9, 2025 | marketbeat.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Shares Bought by HighMark Wealth Management LLCJune 27, 2025 | marketbeat.comCNTA Centessa Pharmaceuticals plc - Seeking AlphaJune 27, 2025 | seekingalpha.comCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 3.8% on Insider SellingJune 26, 2025 | marketbeat.comInsider Selling: Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Insider Sells 10,000 Shares of StockJune 26, 2025 | insidertrades.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Insider Sells $138,600.00 in StockJune 25, 2025 | marketbeat.comIqbal J. Hussain Sells 12,000 Shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) StockJune 25, 2025 | marketbeat.comInsider Selling: Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Insider Sells 15,000 Shares of StockJune 25, 2025 | marketbeat.comCentessa Pharmaceuticals plc's (NASDAQ:CNTA) Intrinsic Value Is Potentially 99% Above Its Share PriceJune 24, 2025 | finance.yahoo.comCentessa Pharmaceuticals Receives FDA Clearance for New Drug ORX142, Initiates Phase 1 StudyJune 24, 2025 | msn.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) CEO Sells $694,650.00 in StockJune 21, 2025 | insidertrades.comCentessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of "Buy" by AnalystsJune 21, 2025 | marketbeat.comCentessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep ...June 18, 2025 | seekingalpha.comCentessa announces clearance of IND for ORX142June 18, 2025 | finance.yahoo.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Bought by GAMMA Investing LLCJune 17, 2025 | marketbeat.comCentessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this YearJune 16, 2025 | globenewswire.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Stake Decreased by Two Sigma Investments LPJune 9, 2025 | marketbeat.comBank of America Corp DE Has $732,000 Stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA)June 9, 2025 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 9.5% - Should You Sell?June 5, 2025 | marketbeat.comCentessa Pharmaceuticals Announces Executive ChangesMay 30, 2025 | investing.comInsider Selling: Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Sells 10,000 Shares of StockMay 29, 2025 | marketbeat.comNeedham Initiates Coverage of Centessa Pharmaceuticals plc - Depositary Receipt () (CNTA) with Buy RecommendationMay 29, 2025 | msn.comCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up - Should You Buy?May 29, 2025 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Now Covered by Needham & Company LLCMay 29, 2025 | marketbeat.comGregory M. Weinhoff Sells 10,000 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) StockMay 28, 2025 | insidertrades.comMillennium Management LLC Raises Holdings in Centessa Pharmaceuticals plc (NASDAQ:CNTA)May 28, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Given Consensus Recommendation of "Buy" by AnalystsMay 28, 2025 | marketbeat.comWoodline Partners LP Buys 29,266 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)May 25, 2025 | marketbeat.comLazard Asset Management LLC Takes Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)May 22, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Director Buys $550,053.36 in StockMay 20, 2025 | insidertrades.comLeerink Partnrs Has Positive Estimate for CNTA Q2 EarningsMay 20, 2025 | marketbeat.comCentessa Pharmaceuticals to Participate in Upcoming Investor ConferencesMay 19, 2025 | globenewswire.comPoint72 Asset Management L.P. Grows Stock Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)May 18, 2025 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Shares Sold by Cubist Systematic Strategies LLCMay 17, 2025 | marketbeat.comJanus Henderson Group PLC Buys 3,614,623 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)May 15, 2025 | marketbeat.comCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025May 14, 2025 | uk.finance.yahoo.comCentessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025May 14, 2025 | finanznachrichten.deCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025May 14, 2025 | globenewswire.comBalyasny Asset Management L.P. Sells 505,993 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)May 14, 2025 | marketbeat.comDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Acquires New Stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA)May 12, 2025 | marketbeat.comVoya Investment Management LLC Makes New Investment in Centessa Pharmaceuticals plc (NASDAQ:CNTA)May 12, 2025 | marketbeat.com Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Email Address CNTA Media Mentions By Week CNTA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTA News Sentiment▼0.550.63▲Average Medical News Sentiment CNTA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTA Articles This Week▼95▲CNTA Articles Average Week Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ROIV News ELAN News RGC News LEGN News RVMD News GRFS News TGTX News NUVL News LNTH News RYTM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTA) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
